Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2025 · 10-Q
Revenue$8.86M$8.86M+9.1% vs Q3 2024 Net Income-$5.89M-$5.89MN/M vs Q3 2024 EPS Diluted-$0.21-$0.21N/M vs Q3 2024 Gross Profit$5,600,000+15.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,121,000N/M Free Cash Flowderived-$3,320,000N/M Margins · derivedGross margin63.2%+3.5 pt vs Q3 2024
Operating margin-59.5%+4.0 pt vs Q3 2024
Net margin-66.5%−5.2 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end